SIBN
SI-BONE, Inc.
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Last price
20.22
▲ 0.74 (3.81%)
MARKET · —
Price
Open
19.47
Prev close
19.48
Day high
20.05
Day low
19.27
Volume
1.29M
Market cap
$894.58M
P/E (TTM)
—
52W range
11.48 – 21.89
Trailing performance
Returnvs SPY
1W
+5.44%
+6.8%
1M
+21.19%
+17.5%
3M
+34.77%
+31.7%
6M
+28.94%
+17.9%
YTD
+1.22%
-11.1%
1Y
+28.44%
+8.4%
3Y
-5.22%
-79.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$894.58M
Enterprise value$791.43M
Revenue (TTM)$213.60M
Gross profit$169.87M
EBITDA$-11.32M
Net income$-14.63M
EPS (TTM)$-0.33
Free cash flow$-861.88K
Total cash$145.94M
Total debt$42.80M
Book value / share$4.08
Shares outstanding44.82M
Float39.88M
Short % of float13.21%
Dividend yield—
Beta (5Y)0.70
Valuation & profitability ratios
Trailing P/E—
Forward P/E-60.33
PEG ratio—
Price / sales—
Price / book4.89
EV / revenue3.71
EV / EBITDA-69.88
Gross margin79.53%
Operating margin-8.58%
Profit margin-6.85%
Return on equity-8.30%
Return on assets-4.62%
Debt / equity23.47
Current ratio9.15
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $200.93M | $167.18M | $138.89M | $106.41M |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | -$18.90M | -$30.91M | -$43.34M | -$61.26M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$18.90M | -$30.91M | -$43.34M | -$61.26M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.15 | -0.09 | +39.9% |
| Mar 2026 | -0.19 | -0.10 | +47.8% |
| Dec 2025 | -0.13 | -0.04 | +68.1% |
| Sep 2025 | -0.17 | -0.11 | +33.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.13 | 8 | $55.32M | +13.7% |
| Next quarter | -0.07 | 8 | $68.23M | +21.1% |
| Current year | -0.40 | 8 | $232.13M | +15.5% |
| Next year | -0.33 | 8 | $268.44M | +15.6% |
Analyst targets & ownership
Mean target$25.00
High target$32.00
Low target$20.00
Implied upside23.63%
Analyst count9
ConsensusSTRONG BUY
Strong buy / Buy3 / 6
Hold0
Sell / Strong sell0 / 0
Held by insiders3.33%
Held by institutions109.72%
Institutions holding242
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
+6.00K
Net buying
Buy transactions
9
100.89K shares
Sell transactions
15
94.89K shares
Net transactions
+24
Buys less sells
Sell : buy shares
0.9 : 1
Mixed
Insider-held shares
1.49M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 17, 26 | PISETSKY MICHAEL A Officer |
SELL | 3.73K | $69.41K | Direct |
| Aug 17, 26 | MAHESHWARI ANSHUL Chief Financial Officer |
SELL | 4.67K | $87.02K | Direct |
| Aug 17, 26 | FRANCIS LAURA A. Chief Executive Officer |
SELL | 14.96K | $279.06K | Direct |
| Aug 3, 26 | DUNN JEFFREY W Director |
SELL | 20.00K | $369.21K | Direct |
| Aug 3, 26 | DUNN JEFFREY W Director |
CONVERSION | 20.00K | $93.60K | Direct |
| Jul 2, 26 | PISETSKY MICHAEL A Officer |
SELL | 3.13K | $52.38K | Direct |
| Jul 2, 26 | MAHESHWARI ANSHUL Chief Financial Officer |
SELL | 3.32K | $55.63K | Direct |
| Jun 5, 26 | DUNN JEFFREY W Director |
SELL | 3.58K | $54.51K | Direct |
| Jun 4, 26 | DAVIS TIMOTHY E JR Director |
STOCK | 10.96K | $0 | Direct |
| Jun 4, 26 | WEST THOMAS A Director |
STOCK | 10.96K | $0 | Direct |
| Jun 4, 26 | DUNN JEFFREY W Director |
STOCK | 10.96K | $0 | Direct |
| Jun 4, 26 | NISHIMURA MIKA Director |
STOCK | 10.96K | $0 | Direct |
| Jun 4, 26 | HILLEMAN JERYL L Director |
STOCK | 10.96K | $0 | Direct |
| Jun 4, 26 | FREUND JOHN GORDON Director |
STOCK | 10.96K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
DAVIS TIMOTHY E JR |
Director | 76.68K | Stock Award(Grant) |
DUNN JEFFREY W |
Director | 97.13K | Sale |
FRANCIS LAURA A. |
Chief Executive Officer | 867.17K | Sale |
FREUND JOHN GORDON |
Director | 146.03K | Stock Award(Grant) |
HILLEMAN JERYL L |
Director | 43.77K | Stock Award(Grant) |
HINCKLEY GREGORY K |
Director | 180.74K | Conversion of Exercise of derivative security |
MAHESHWARI ANSHUL |
Chief Financial Officer | 251.90K | Sale |
NISHIMURA MIKA |
Director | 43.67K | Stock Award(Grant) |
PISETSKY MICHAEL A |
Officer | 273.65K | Sale |
RECUPERO ANTHONY JOHN |
Former | 243.42K | Sale |
Moving averages & technicals
SMA 10
19.17
+5.49% from price
SMA 20
18.63
+7.15% from price
SMA 50
17.44
+14.46% from price
SMA 100
15.63
+29.38% from price
SMA 200
16.27
+22.68% from price
EMA 12
19.08
+5.97% from price
EMA 26
18.42
+9.79% from price
EMA 50
17.54
+15.28% from price
RSI (14)
67.6
Neutral
MACD (12,26,9)
0.66
Hist 0.07
ATR (14)
0.70
3.51% of price
Realised vol 30D
36.7%
Annualised
Bollinger upper
20.02
20, 2σ
Bollinger lower
17.24
20, 2σ
50 / 200 cross
Golden
17.44 vs 16.27
Trend bias
Above 200
+22.68%
Risk profile
Beta vs SPY
0.70
Less volatile than market
Correlation to SPY
0.18
Largely independent
Realised vol 30D
36.7%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-45.7%
Peak to trough
Max drawdown 5Y
-59.8%
Peak to trough
ATR 14
0.70
3.51% of price
Beta (reported)
0.70
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.00
Call-heavy session
Put / call open interest
0.04
Positioning, not flow
Max pain
15.00
-24.8% from spot
ATM implied vol
57.6%
Nearest strike to spot
Skew (10% OTM)
+53.1%
Puts bid over calls
Call volume
9
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
20.00
25 contracts
Heaviest put OI
15.00
1 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Si-Bone Insider Sold Shares Worth $337,138, According to a Recent SEC Filing
MT Newswires · 20h ago
Si-Bone Insider Sold Shares Worth $1,088,201, According to a Recent SEC Filing
MT Newswires · 20h ago
SI-BONE (SIBN) Q2 2026 Earnings Call Transcript
Motley Fool · 12d ago
Does Si-Bone (SIBN) Have the Potential to Rally 38.58% as Wall Street Analysts Expect?
Zacks · 16d ago
UBS Lifts Price Target on SI-BONE to $25 From $24, Maintains Buy Rating
MT Newswires · 18d ago
SI-BONE, Inc. Q2 2026 Earnings Call Summary
Moby · 18d ago
Truist Adjusts Price Target on SI-BONE to $23 From $21, Maintains Buy Rating
MT Newswires · 18d ago
SI-BONE Inc (SIBN) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised ...
GuruFocus.com · 19d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.